Small molecule drug development using proprietary technology to screen interactions with human proteins, in target-specific programs to present as clinical-stage compounds. Profile of company based in San Diego, California.
Developer of proteomics-based diagnostic products for the early detection of cancer by identifying proteins correlated with breast, bladder, prostate, cervical and colon cancers. Located in Newton, Massachusetts.
Specializes in interpretation of 2-dimensional gels, and developing point-of-care diagnostics in the areas of cystic fibrosis, cancer, infectious disease and aging. Includes alpha-amylase test, and research programs, with contacts in USA, Japan and headquarters in Sydney, Australia.
